Public research preview
Undisclosed SIX management transaction party T1Q5T000F0, A non-executive member of the board of directors of Basilea Pharmaceutica AG, Allschwil
Disclosed a sell transaction in Basilea Pharmaceutica AG, Allschwil. Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- SIX management transactions
- Published
- 29 May 2026, 00.00
- Parser confidence
- 96%
- Instrument mapping
- 85%
- Filing delay
- 0 days
Timeline
Transaction date
29 May 2026
Public disclosure
29 May 2026
Now
Tracked today
Filing delay: 0 days
Price movement
Complete coverage
- Provider
- EODHD global daily close
- Fetched
- 5 Jun 2026
Stock path
BSLN from pre-transaction context through latest close.
Transaction
29 May 2026 · 52,1 CHF
- Observed transaction close
- 52,1
- Observed disclosure close
- 52,1
- Observed latest close
- 49,7
- Pre-disclosure move
- 0.0%
- Post-disclosure move
- -4.6%
- Market-adjusted move
- -4.6%
Why Copy Window is Still fresh
Supporting factors
- Parsed sell disclosure for ordinary shares from SIX management transactions.
- Transaction value is CHF 20,800.
- Post-disclosure move is calculated from EODHD global daily close daily closes.
Cautions
- EODHD global daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
SIX management transactions, published 29 May 2026, 00.00
- Parser confidence
- 96%
- Instrument mapping
- 85%